The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia

被引：1
|
作者：
Fernando, Fiona [1 ,2 ]
Innes, Andrew J. [1 ,2 ]
Claudiani, Simone [1 ,2 ]
Pryce, Angharad [1 ,2 ]
Hayden, Chloe [3 ]
Byrne, Jenny [4 ]
Gallipoli, Paolo [5 ]
Copland, Mhairi [6 ]
Apperley, Jane F. [1 ,2 ]
Milojkovic, Dragana [1 ,2 ]
机构：
[1] Imperial Coll London, Ctr Haematol, London, England
[2] Imperial Coll Healthcare NHS Trust, Dept Clin Haematol, London, England
[3] Imperial Coll Healthcare NHS Trust, Hammersmith Hosp, North West London Pathol, London, England
[4] Nottingham Univ Hosp NHS Trust, Ctr Clin Haematol, Nottingham, England
[5] Queen Mary Univ London, Barts Canc Inst, Ctr Haemato Oncol, London, England
[6] Univ Glasgow, Paul OGorman Leukaemia Res Ctr, Sch Canc Sci, Glasgow, Scotland
来源：
BONE MARROW TRANSPLANTATION | 2023年 / 58卷 / 07期
关键词：
HEMATOPOIETIC-CELL TRANSPLANTATION; ACUTE LYMPHOBLASTIC-LEUKEMIA; RELAPSE;
D O I：
10.1038/s41409-023-01975-9
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：826 / 828
页数：3
相关论文
共 50 条
  • [1] The outcome of post-transplant asciminib in patients with chronic myeloid leukaemia
    Fiona Fernando
    Andrew J. Innes
    Simone Claudiani
    Angharad Pryce
    Chloe Hayden
    Jenny Byrne
    Paolo Gallipoli
    Mhairi Copland
    Jane F. Apperley
    Dragana Milojkovic
    Bone Marrow Transplantation, 2023, 58 : 826 - 828
  • [2] Post-transplant Outcome in Chronic Myeloid Leukaemia
    Raza, Shahid
    Ullah, Khalil
    Ahmed, Parvez
    Khan, Badshah
    Kamal, Muhammad Khalid
    JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN, 2008, 18 (10): : 615 - 619
  • [3] Asciminib for chronic myeloid leukaemia: Next questions
    Shanmuganathan, Naranie
    Hughes, Timothy P.
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 199 (03) : 322 - 331
  • [4] Prognostic impact of post-transplant detectable minimal measurable in acute myeloid leukaemia patients
    Klyuchnikov, E.
    Christopeit, M.
    Badbaran, A.
    Bacher, U.
    Fritzsche-Friedland, U.
    von Pein, U. -M.
    Wolschke, C.
    Kroeger, N.
    ONCOLOGY RESEARCH AND TREATMENT, 2019, 42 : 256 - 256
  • [5] Cytogenetic risk groups and minimal residual disease are strong prognostic factors for post-transplant outcome in patients with acute myeloid leukaemia
    Blau, O.
    Burmeister, T.
    Rieger, K.
    Schwartz, S.
    Baldus, C.
    Uharek, L.
    Tuerkmen, S.
    Sindram, A.
    Thiel, E.
    Blau, I. W.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S198 - S198
  • [6] Haploidentical Transplant with Post-Transplant Cyclophosphamide for Acute Myeloid Leukaemia and Myelodysplastic Syndromes Patients: The Role of Previous Lines of Therapy
    Avenoso, Daniele
    Serpenti, Fabio
    Slonim, Liron Barnea
    Bouziana, Styliani
    Dazzi, Francesco
    Hannah, Guy
    Kenyon, Michelle
    Mehra, Varun
    Kulasekararaj, Austin
    Krishamurthy, Pramila
    Shah, Mili Naresh
    Lionel, Sharon
    Pagliuca, Antonio
    Potter, Victoria
    MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES, 2024, 16 (01)
  • [7] Evaluation of allogeneic haematopoietic stem cell transplantation and pre- and post-transplant therapy in high-risk patients with chronic myeloid leukaemia
    Oyekunle, A.
    Klyuchnikov, E.
    Kroeger, N.
    Zabelina, T.
    Ayuk, F.
    Wolschke, C.
    Bernhardt, F.
    Mueller, I.
    Zander, A.
    Bacher, U.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S363 - S363
  • [8] The outcome of post-transplant lymphoproliferative disease in four patients
    Ramadan, KMA
    Bowers, M
    El-Agnaf, MR
    Kettle, P
    BRITISH JOURNAL OF HAEMATOLOGY, 2005, 129 : 63 - 64
  • [9] Imatinib or transplant for chronic myeloid leukaemia?
    Craddock, C
    Augustson, B
    Basu, S
    LANCET, 2003, 362 (9378): : 173 - 173
  • [10] The Presence of Minimal Residual Disease Pre- and Post-Transplant Is Predictive of Outcome in Recipients of Allogeneic Transplantation for Acute Myeloid Leukaemia
    Dignan, Fiona L.
    Anthias, Chloe
    Ethell, Mark E.
    Morilla, Ricardo
    Morilla, Alison
    Davies, Faith E.
    Morgan, Gareth J.
    Potter, Michael N.
    Shaw, Bronwen E.
    BLOOD, 2009, 114 (22) : 1020 - 1021
12345